Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC, Bristol-Myers Squibb Drugs

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks.jpg" NAME"Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca, Bristol-Myers Squibb Drugs" ALT"Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca, Bristol-Myers Squibb Drugs"April 10, 2017By <A HREF"http://www.biospace.com/news_subject_all_results.aspx?CatagoryId…
Source: BioSpace